Aurobindo Pharma, Aurobindo, USFDA, Generic Venlafaxine, Aurobindo Pharma Share Price - YReach.com

Aurobindo Pharma today said it has received tentative approval from the US health regulator, Federal Drug Administration, to market its generic Venlafaxine capsules used for treating major depressive disorder (MDD).

Amplify’d from www.yreach.com

Aurobindo Pharma shares show volatility on US Federal directives over Venlafaxine

Aurobindo Pharma today said it has received tentative approval from the US health regulator , Federal Drug Administration, to market its generic Venlafaxine capsules used for treating major depressive disorder (MDD).

The product will be launched after the litigation settlement. The Venlafexine drug was first introduced by Wyeth in 1993, now marketed by Pfizer, it is licensed for the treatment of major depressive disorder (MDD), as a treatment for generalized anxiety disorder, and comorbid indications in certain anxiety disorders with depression Read more at www.yreach.com

 

See this Amp at http://amplify.com/u/brlea